Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Mycoplasma Testing Market, by Product & Service
1.4.2 North America Mycoplasma Testing Market, by Technology
1.4.3 North America Mycoplasma Testing Market, by Application
1.4.4 North America Mycoplasma Testing Market, by End User
1.4.5 North America Mycoplasma Testing Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.3 Porter Five Forces Analysis
Chapter 4. North America Mycoplasma Testing Market by Product & Service
4.1 North America Kits & Reagents Market by Country
4.2 North America Instruments Market by Country
4.3 North America Services Market by Country
Chapter 5. North America Mycoplasma Testing Market by Technology
5.1 North America PCR Market by Country
5.2 North America ELISA Market by Country
5.3 North America Microbial Culture Techniques Market by Country
5.4 North America Enzymatic Methods Market by Country
Chapter 6. North America Mycoplasma Testing Market by Application
6.1 North America Cell Line Testing Market by Country
6.2 North America Virus Testing Market by Country
6.3 North America End of Production Cells Testing Market by Country
6.4 North America Others Market by Country
Chapter 7. North America Mycoplasma Testing Market by End User
7.1 North America Pharmaceutical & Biotechnology Companies Market by Country
7.2 North America Contract Research Organizations Market by Country
7.3 North America Academic Research Institutes Market by Country
7.4 North America Cell Banks Market by Country
7.5 North America Others Market by Country
Chapter 8. North America Mycoplasma Testing Market by Country
8.1 US Mycoplasma Testing Market
8.1.1 US Mycoplasma Testing Market by Product & Service
8.1.2 US Mycoplasma Testing Market by Technology
8.1.3 US Mycoplasma Testing Market by Application
8.1.4 US Mycoplasma Testing Market by End User
8.2 Canada Mycoplasma Testing Market
8.2.1 Canada Mycoplasma Testing Market by Product & Service
8.2.2 Canada Mycoplasma Testing Market by Technology
8.2.3 Canada Mycoplasma Testing Market by Application
8.2.4 Canada Mycoplasma Testing Market by End User
8.3 Mexico Mycoplasma Testing Market
8.3.1 Mexico Mycoplasma Testing Market by Product & Service
8.3.2 Mexico Mycoplasma Testing Market by Technology
8.3.3 Mexico Mycoplasma Testing Market by Application
8.3.4 Mexico Mycoplasma Testing Market by End User
8.4 Rest of North America Mycoplasma Testing Market
8.4.1 Rest of North America Mycoplasma Testing Market by Product & Service
8.4.2 Rest of North America Mycoplasma Testing Market by Technology
8.4.3 Rest of North America Mycoplasma Testing Market by Application
8.4.4 Rest of North America Mycoplasma Testing Market by End User
Chapter 9. Company Profiles
9.1 Charles River Laboratories International, Inc.
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.2 Thermo Fisher Scientific, Inc.
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expenses
9.2.5 SWOT Analysis
9.3 Eurofins Scientific SE
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Regional Analysis
9.3.4 Recent strategies and developments:
9.3.4.1 Product Launches and Product Expansions:
9.3.4.2 Acquisition and Mergers:
9.3.5 SWOT Analysis
9.4 Lonza Group Ltd.
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.4.4 Research & Development Expenses
9.4.5 SWOT Analysis
9.5 Bio-Rad laboratories, Inc.
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expenses
9.5.5 SWOT Analysis
9.6 InvivoGen SAS
9.6.1 Company Overview
9.6.2 SWOT Analysis
9.7 Asahi Kasei Corporation
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expenses
9.7.5 SWOT Analysis
9.8 F. Hoffmann-La Roche Ltd.
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Segmental and Regional Analysis
9.8.4 Research & Development Expense
9.8.5 SWOT Analysis
9.9 Norgen Biotek Corp.
9.9.1 Company Overview
9.10. PromoCell GmbH
9.10.1 Company Overview
9.10.2 SWOT Analysis
Unique Offerings 